This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,169.59 firm fixed-price delivery order is for the supply of 120 tablets of the pharmaceutical product Xtandi 40 mg. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct awards. Through this and other prime vendor contracts, DMS Pharmaceutical Group serves as a crucial supplier in the federal pharmaceutical supply chain, providing both routine and specialized medications to military personnel and their dependents.
Generated 1/14/25, 9:21 AM